trial

Social Cognition Training in Schizophrenia

NCTId NCT01206842
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 48 (actual)
Sponsored by Oslo University Hospital
Primary completion 2018-05-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
48 (actual)
Study type
Interventional
Allocation
Randomized
Model
Single Group
Masking
Single
Start
2011-08
Primary completion
2018-05-01
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Training in Affect Recognition

Sponsors

Oslo University HospitalLead Sponsor

Investigators

1
Anja Vaskinn, PhDPrincipal Investigator

Sites

1 total
Oslo, Norway

Facts & assertions

4 sourced
Enrollment
48
Phase
NA
Primary Completion Date
2018-05-01
Status
COMPLETED
relationships
The graph out of here
drug
Training in Affect Recognition
drug
lead_sponsor
Oslo University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
Social Cognition
indication
investigator
Anja Vaskinn, PhD
person